BridgeBio Pharma prices $550M convertible bond offering

2026-01-16 05:03:45 ET

More on BridgeBio Pharma

• BridgeBio Pharma, Inc. (BBIO) Presents at 44th Annual J.P. Morgan Healthcare Conference Prepared Remarks Transcript
• BridgeBio Pharma, Inc. (BBIO) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
• BridgeBio Pharma, Inc. (BBIO) Discusses Achondroplasia Pathophysiology, Unmet Needs, and PROPEL 3 Infigratinib Phase 3 Study - Slideshow
• BridgeBio plans $550M convertible notes offering due 2033
• BridgeBio targets 30%+ market share for Attruby while advancing late-stage pipeline and reporting $120.7M Q3 revenue

Read the full article on Seeking Alpha

For further details see: